HGF-Antagonists: Structure, Activities, and Anti-cancer Approach

Publisher： Bentham Science Publishers

E-ISSN： 2212-389x|6|2|191-199

ISSN： 1574-3624

Source： Current Signal Transduction Therapy, Vol.6, Iss.2, 2011-05, pp. : 191-199

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Potential for Substance P Antagonists as Anti-Cancer Agents in Brain Tumours

By  

Recent Patents on CNS Drug Discovery, Vol. 8, Iss. 1, 2013-04 ,pp. : 13-23

Bentham Science Publishers

Access to resources Recommend Favorite

Advancing Drug Therapy for Brain Tumours: A Current Review of the Pro-inflammatory Peptide Substance P and its Antagonists as Anti-cancer Agents

By  

Recent Patents on CNS Drug Discovery, Vol. 9, Iss. 2, 2014-08 ,pp. : 110-121

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of the anticancer activities of thioflavanone and thioflavone in human breast cancer cell lines

By      

International Journal of Molecular Medicine, Vol. 29, Iss. 2, 2012-01 ,pp. : 252-256

Spandidos Publications

Access to resources Recommend Favorite

HGF as Angiogenic Factor and Therapeutic Approach

By  

Current Signal Transduction Therapy, Vol. 6, Iss. 2, 2011-05 ,pp. : 221-227

Bentham Science Publishers

Access to resources Recommend Favorite

HGF and RhoGTPases in Cancer Cell Motility

By  

Current Signal Transduction Therapy, Vol. 6, Iss. 2, 2011-05 ,pp. : 173-179

Bentham Science Publishers

Access to resources Recommend Favorite